newsletter
The Altascientist
THE ALTASCIENTIST JANUARY 2019 ISSUE NO. 7
Effective pharmaceutical therapies — Understanding the intrinsic and extrinsic factors that alter exposure to limit adverse effects and maximize treatment response
SELECT A CATEGORY BELOW
NEWSLETTER
-
Newsletter
January 2015
The Algorithme Pharma team provides full bioanalytical support for Large Molecules through all phases of clinical development, including as part of regulated studies.
The Algorithme Pharma team provides full bioanalytical support for Large Molecules through all phases of clinical development, including as part of regulated studies.
-
Newsletter
Vince & Associates Clinical Research - Newsletter January 2015
Vince & Associates’ Stellar Regulatory History, Pharmacology Unit Expansion, Joins The Cardiac Safety Research Consortium, Qualified as Early Phase Provider for Clinical Evaluation of Thorough QT and Upcoming Presentations.
-
Newsletter
November 2014
The impact of new partial AUC parameters for evaluating the bioequivalence of prolonged-release formulations, Thank you to everyone who joined us at the AAPS Annual Meeting in San Diego and Don't miss the 7th EBF Open Symposium!
-
Newsletter
October 2014
Development and Validation of an ELISA for the Determination of AB-16B5 in Rat Serum, AAPS Annual Meeting, San Diego, Webinar — Impaired Renal Function Clinical Trials: Early Phase Planning to Minimize Risks and Accelerate Drug Development and 7th Open Symposium of EBF.
-
Newsletter
Vince & Associates Clinical Research - Newsletter September 2014
Vince & Associates Clinical Research Awarded $5 Million FDA Contract to Conduct Clinical Studies, provides Platinum Sponsorship for the 6th Annual Pain Therapeutics Summit and CWWeekly’s semi-monthly company profile feature.
-
Newsletter
September 2014
Biologics & Biosimilars: Key Considerations & Strategies in Early Stage Development and Overcoming the Bioanalysis Challenges of Biosimilars: Rituximab Case Study.
-
Newsletter
August 2014
Improving Patient Recruitment for Early Phase Clinical Trials, Customizable First-In-Human Trial Gantt Chart and Bioanalysis Journal: Choosing the appropriate matrix to perform a scientifically meaningful lipemic plasma test in bioanalytical method validation.